Cargando…
Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India
BACKGROUND: The Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) trial established a new benchmark in the management of oesophageal cancer with neoadjuvant chemoradiation followed by surgery with a marked benefit for squamous cell carcinomas (SCCs). We evaluate if the CROSS...
Autores principales: | Bhattacharyya, Tapesh, Arunsingh, Moses, Chakraborty, Santam, Harilal, Vishnu, Sasidharan, Rohit, Saha, Saheli, Thambudorai, Robin, Roy, Bipradas, Banerjee, Sudeep, Roy, Paromita, Ray, Soumendranath, Mallick, Indranil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580591/ https://www.ncbi.nlm.nih.gov/pubmed/34824614 http://dx.doi.org/10.3332/ecancer.2021.1291 |
Ejemplares similares
-
Real-world results of definitive chemoradiation in carcinoma oesophagus: can SCOPE1 results be replicated outside trial setting?
por: Bhattacharyya, Tapesh, et al.
Publicado: (2021) -
Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center
por: Basu Achari, Rimpa, et al.
Publicado: (2022) -
Geographic disparities in access to cancer clinical trials in India
por: Chakraborty, Santam, et al.
Publicado: (2021) -
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
por: Mallick, Indranil, et al.
Publicado: (2021) -
ICON-P – A double-blind evaluation of quality improvements with individualized CONstraints from low-cost knowledge-based radiation therapy planning in prostate cancer
por: Saha, Saheli, et al.
Publicado: (2023)